Significant Accounting Policies and Concentrations of Risk Textual (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Apr. 17, 2023
Significant Accounting Policies and Concentrations of Risk [Line Items]
Restricted cash	$ 1,610,000	$ 1,804,000
Restricted cash	210,000	1,804,000	$ 1,472,000
Birmingham lease restricted cash	$ 1,400,000
Long-term investment maturity, minimum (in months)	12 months
Advertising expense	$ 13,566,000	14,404,000	$ 14,891,000
Reclassification from accumulated other comprehensive income, current period, before tax	$ 0	0
Computer Equipment
Significant Accounting Policies and Concentrations of Risk [Line Items]
Property, plant and equipment, useful life (in years)	3 years
Furniture and fixtures
Significant Accounting Policies and Concentrations of Risk [Line Items]
Property, plant and equipment, useful life (in years)	5 years
Collateral for Credit
Significant Accounting Policies and Concentrations of Risk [Line Items]
Restricted cash	$ 1,400,000	1,493,000
Maximum
Significant Accounting Policies and Concentrations of Risk [Line Items]
Maturity period of high quality marketable securities (in years)	2 years
Average maturity period of high quality marketable securities (in months)	12 months
Maturity period of short term investment (in months)	12 months
Pharmakon Advisors, LP | Term Loan Tranche A | Line of Credit
Significant Accounting Policies and Concentrations of Risk [Line Items]
Interest expense, debt, total	$ 39,874,000	$ 27,326,000
Debt instrument, face amount				$ 300,000,000